Combinatorial and Sequential Targeted Therapy in Metastatic Renal Cell Carcinoma
Combinations Author, pub date # of patients Outcomes Combinations of targeted agents Bevacizumab and everolimus Hainesworth, 2010 [6] 80 Median PFS 9.1 months in untreated patients, 7.1 months patients previously…